Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 24 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT07075939
- Conditions
- Adnexal Diseases, Advanced Ovarian Cancer, COVID-19, +30 more
- Locations
-
- Azienda Unità - Sanitaria locale di Modena - Ospedale Razzini Carpi Carpi, Modena, Italy
- Azienda Unità - Sanitaria locale di Modena - Ospedale di Mirandola Mirandola, Modena, Italy
- Azienda Unità - Sanitaria locale di Modena - Ospedale Pavullo nel Frignano Pavullo nel Frignano, Modena, Italy
- Azienda Unità - Sanitaria locale di Modena - Ospedale Civile Sassuolo Sassuolo, Modena, Italy
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
NCT06997029
- Conditions
- Advanced Breast Cancer, Advanced Ovarian Cancer, Advanced Solid Tumor, +1 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Providence St. Jude Medical Center Fullerton, California, United States
- Marin Cancer Care Greenbrae, California, United States
- Moores Cancer Center La Jolla, California, United States
NCT06547840
- Conditions
- Advanced Endometrial Cancer, Advanced Ovarian Cancer, Breast Diseases, +20 more
- Locations
-
- Bristol Haematology and Oncology Centre Bristol, United Kingdom
- Edinburgh Cancer Research Centre Edinburgh, United Kingdom
- Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom
- Cambridge University - Addenbrooke's Hospital London, United Kingdom
Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer
NCT03878849
- Conditions
- Advanced Ovarian Cancer
- Locations
-
- OU Health Stephenson Cancer Oklahoma City, Oklahoma, United States
- Swedish Center for Research and Innovation Seattle, Washington, United States
NCT07120451
- Conditions
- Advanced Ovarian Cancer
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT07059676
- Conditions
- Advanced Ovarian Cancer
- Locations
-
Not specified
Efficacy and Safety of AK104 (PD-1/CTLA-4 Bispecial Antibody) Combined With Chemotherapy for Neoadjuvant Treatment of Advanced Ovarian Cancer
NCT06542549
- Conditions
- AK104(PD-1/CTLA-4 Bispecial Antibody), Advanced Ovarian Cancer, Chemotherapy, +2 more
- Locations
-
Not specified
Plasmodium Immunotherapy for Advanced Ovarian Cancer
NCT05924776
- Conditions
- Advanced Ovarian Cancer, Infections, Malaria, +5 more
- Locations
-
- The Third Affiliated Hospital of Southern Medical University Guangzhou, Guangdong, China
Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer
NCT05794659
- Conditions
- Advanced Ovarian Cancer
- Locations
-
- University of Washington Seattle, Washington, United States
NCT07648940
- Conditions
- Advanced Ovarian Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Adium S.A. São Paulo, Brazil
NCT00516724
- Conditions
- Advanced Ovarian Cancer, Carboplatin, Paclitaxel, +1 more
- Locations
-
- Research Site Brussels, Belgium
- Research Site Amsterdam, Netherlands
- Research Site Rotterdam, Netherlands
- Research Site London, United Kingdom
NCT05775549
- Conditions
- Advanced Ovarian Cancer
- Locations
-
- Research Site Tampa, Florida, United States
- Research Site Shreveport, Louisiana, United States
- Research Site Annapolis, Maryland, United States
- Research Site Baltimore, Maryland, United States
NCT03161132
- Conditions
- Advanced Ovarian Cancer
- Locations
-
- Corporación Sanitaria Parc Taulí Sabadell, Barcelona, Spain
- Hospital Universitario de Gran Canaria Doctor Negrín Las Palmas de Gran Canaria, Gran Canaria, Spain
- Hospital Son Llatzer Palma de Mallorca, Mallorca, Spain
- Hospital Universitario Ramón y Cajal Madrid, Spain
NCT04360629
- Conditions
- Advanced Ovarian Cancer
- Locations
-
- Shanghai Cancer Center, Fudan University Shanghai, Shanghai Municipality, China
NCT01989546
- Conditions
- Advanced Breast Cancer, Advanced Ovarian Cancer, Advanced Solid Tumors, +1 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT03158935
- Conditions
- Advanced Ovarian Cancer, Malignant Melanoma, Melanoma, +11 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
NCT04135521
- Conditions
- Advanced Ovarian Cancer
- Locations
-
- Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital Banqiao District, New Taipei, Taiwan
NCT01462149
- Conditions
- Advanced Ovarian Cancer
- Locations
-
- Asan Medical Center Seoul, South Korea
NCT01290471
- Conditions
- Advanced Ovarian Cancer, Advanced Solid Malignant Tumors
- Locations
-
- Karmanos Cancer Center Detroit, Michigan, United States
- Univ. Oklahoma Health Science Center Oklahoma City, Oklahoma, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients
NCT03737643
- Conditions
- Adnexal Diseases, Advanced Ovarian Cancer, Endocrine Gland Neoplasms, +13 more
- Locations
-
- Research Site Foothill Ranch, California, United States
- Research Site Los Angeles, California, United States
- Research Site Orange, California, United States
- Research Site San Francisco, California, United States